Public market insider buying at Wesana Health Holdings (WESA)

Public market insider buying at Wesana Health Holdings (C:WESA)

The K2 Principal Fund L.P., a 10% Holder, acquired 76,500 Common Shares on a direct ownership basis at prices ranging from $2.900 to $2.989 between September 28th, 2021 and October 1st, 2021. This represents a $226,476 investment into the company's shares and an account share holdings change of 4.6%.

Wesana Health Holdings is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma.